Members |
targetComponentId |
[M]Acute monocytic leukaemia |
Acute monocytic leukemia |
[M]Choroid plexus papilloma NOS |
Benign choroid plexus papilloma (morphologic abnormality) |
[M]Chronic erythraemia |
Polycythemia vera |
[M]Chronic lymphoid leukaemia |
B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma |
[M]Chronic monocytic leukaemia |
Chronic myelomonocytic leukemia |
[M]Dermoid cyst |
Teratoma, benign |
[M]Eccrine dermal cylindroma |
Eccrine dermal cylindroma |
[M]Extra-adrenal paraganglioma, NOS |
Extra-adrenal paraganglioma (disorder) |
[M]Glioma NOS |
Glioma, malignant (morphologic abnormality) |
[M]Gliomas |
Glioma |
[M]Leukaemic reticuloendotheliosis |
Hairy cell leukemia |
[M]Megakaryocytic leukaemia |
Acute megakaryoblastic leukemia |
[M]Mycosis fungoides |
Mycosis fungoides |
[M]Subependymal astrocytoma NOS |
Subependymal glioma |
[M]Waldenstrom's macroglobulinaemia |
Waldenstrom's macroglobulinemia |
[Myelin basic protein]-arginine N-methyltransferase |
Histone-arginine N-methyltransferase (substance) |
[Pyruvate dehydrogenase (lipoamide)]-phosphatase |
Pyruvate dehydrogenase lipoamide-phosphatase |
acute myocardial infarction of posterolateral wall (disorder) |
Acute myocardial infarction of posterolateral wall |
alpha Chloralose |
Alphachloralose |
alpha-Amylase (substance) |
Alpha-amylase (substance) |
alpha-amylase-præparat |
Alpha-amylase (substance) |
alpha-Glucosidase (substance) |
Alpha-glucosidase (substance) |
alpha-Lactalbumin (substance) |
Alpha-lactalbumin (substance) |
alpha-N-Acetylgalactosaminidase |
N-Acetyl-alpha-galactosaminidase |
alpha>1< Antichymotrypsin |
Alpha-1-antichymotrypsin |
alpha>1< Glycoprotein |
Alpha-1- acid glycoprotein (substance) |
alpha>2< Antiplasmin |
Antiplasmin |
alpha>2< Globulin |
Alpha 2 globulin |
betacarotenpræparat |
Product containing betacarotene (medicinal product) |
beta-Amylase (substance) |
Beta-amylase (substance) |
beta-Hydroxybutyrate |
3-hydroxybutyrate |
day |
day |
de Barsy-syndrom |
A syndrome with characteristics of facial dysmorphism, a progeroid appearance, large and late closing fontanelle, cutis laxa, joint hyperlaxity, athetoid movements and hyperreflexia, pre and postnatal growth retardation, intellectual deficit and developmental delay, and corneal clouding and cataract. |
degrees of arc |
degrees of arc |
delta Aminolevulinic acid |
5-aminolevulinic acid (substance) |
delta-Aminolevulinic acid |
5-aminolevulinic acid (substance) |
tandlægepraksis |
Dental clinic |
dsDNA binding autoantibody level |
Antibody to double stranded DNA measurement |
dsDNA binding autoantibody level |
Antibody to double stranded DNA measurement |
Pteroyl-poly-alpha-glutamate hydrolase |
Gamma-glutamyl hydrolase (substance) |
gamma-Hydroxybutyrate |
4-hydroxybutyrate |
hjemmebesøg (procedure) |
Home visit (procedure) |
mL/s |
mL/s |
mmol/g dry weight tissue |
mmol/g dry weight tissue |
n-Acetyl glucosamine |
N-Acetylglucosamine |
n-Butylglycidylether |
N-butyl glycidyl ether |
n-Caproic acid |
Caproic acid |
n-Hexane |
Hexane |
n-Hexane measurement |
Hexane measurement |
n-Methyl-3, 4-methylenedioxyamphetamine |
Methylenedioxymethamphetamine |
n-Pentane |
Pentane |
n-Propyl alcohol |
Propanol |
n-Valeric acid |
Valeric acid |
o-Phenylphenol |
2-phenylphenol |
oz |
oz |
oz |
oz |
p-29 antibody |
Antiproteinase 3 antibody |
p-Chlorometacresol |
Chlorocresol |
p-Nitrophenol |
Para-nitrophenol |
p-tert-Butylphenol |
p-tert-butylphenol (substance) |
pM category |
pM category (observable entity) |
pN category |
pN category (observable entity) |
pT category |
pT category (observable entity) |
r' phenotype |
cde haplotype (finding) |
rehabiliteringscenter |
Rehabilitation clinic (environment) |
ssDNA binding autoantibody level |
Antibody to single stranded DNA measurement |
ssDNA binding autoantibody level |
Antibody to single stranded DNA measurement |
tRNA cytidylyltransferase |
tRNA adenylyltransferase |
tRNA nucleotidyltransferase |
tRNA adenylyltransferase |
takotsubo kardiomyopati |
Takotsubo cardiomyopathy |
ukg |
ug/kg |
van der Hoeves syndrom |
Osteogenesis imperfecta type I (disorder) |
von Frey's syndrome |
Auriculotemporal syndrome |
von Willebrands sygdom type 2N |
Hereditary von Willebrand disease type 2N (disorder) |
von Willebrand disease type 2A |
Hereditary von Willebrand disease type 2A |
von Willebrands sygdom type 2A |
Hereditary von Willebrand disease type 2A |
von Willebrand disease type 2B |
Hereditary von Willebrand disease type 2B |
von Willebrands sygdom type 2B |
Hereditary von Willebrand disease type 2B |
von Willebrands sygdom type 2M |
Hereditary von Willebrand disease type 2M |
von Willebrand disease type 2M |
Hereditary von Willebrand disease type 2M |
von Willebrand disease type 2N |
Hereditary von Willebrand disease type 2N (disorder) |
von Willebrands sygdom type IA |
Hereditary von Willebrand disease type 1A |
von Willebrand disease type IA |
Hereditary von Willebrand disease type 1A |
von Willebrands sygdom type IIA |
Hereditary von Willebrand disease type 2A |
von Willebrands sygdom type IIB |
Hereditary von Willebrand disease type 2B |
von Willebrand factor activity |
Von Willebrand factor activity measurement (procedure) |
von Willebrand factor activity |
Von Willebrand factor activity measurement (procedure) |
von Willebrand factor antigen |
von Willebrand factor antigen |
von Willebrand factor level |
Factor VIII R: WF assay |
von Willebrand factor level |
Factor VIII R: WF assay |
von Willebrand factor multimeric analysis |
von Willebrand factor multimer assay |
von Willebrand factor ristocetin cofactor |
von Willebrand factor |
von Willebrand's disease |
Includes true von Willebrand disease with mutation at the VWF locus, as well as mimicking disorders with other mutations (pseudo VWD) and acquired von Willebrand syndrome. |